These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 457253)

  • 41. Purification of alpha-toxin from Staphylococcus aureus and application to cell permeabilization.
    Lind I; Ahnert-Hilger G; Fuchs G; Gratzl M
    Anal Biochem; 1987 Jul; 164(1):84-9. PubMed ID: 3674374
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cross-neutralization of staphylococcal and streptococcal pyrogenic toxins by monoclonal and polyclonal antibodies.
    Bohach GA; Hovde CJ; Handley JP; Schlievert PM
    Infect Immun; 1988 Feb; 56(2):400-4. PubMed ID: 2448242
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Superantigenic exotoxin production by isolates of Staphylococcus aureus from the Kawasaki syndrome patients and age-matched control children.
    Todome Y; Ohkuni H; Mizuse M; Okibayashi F; Ohtani N; Suzuki H; Song C; Igarashi H; Harada K; Sakurai S
    J Med Microbiol; 1995 Feb; 42(2):91-5. PubMed ID: 7869353
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enhancement of host susceptibility to lethal endotoxin shock by staphylococcal pyrogenic exotoxin type C.
    Schlievert PM
    Infect Immun; 1982 Apr; 36(1):123-8. PubMed ID: 7042568
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Toxic shock syndrome-associated staphylococcal and streptococcal pyrogenic toxins are potent inducers of tumor necrosis factor production.
    Fast DJ; Schlievert PM; Nelson RD
    Infect Immun; 1989 Jan; 57(1):291-4. PubMed ID: 2642470
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Purification and some properties of Shiga-like toxin from Escherichia coli O157:H7 that is immunologically identical to Shiga toxin.
    Noda M; Yutsudo T; Nakabayashi N; Hirayama T; Takeda Y
    Microb Pathog; 1987 May; 2(5):339-49. PubMed ID: 3148810
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Separation of mitogenic and pyrogenic activities from so-called erythrogenic toxin type B (Streptococcal proteinase).
    Gerlach D; Reichardt W; Fleischer B; Schmidt KH
    Zentralbl Bakteriol; 1994 Mar; 280(4):507-14. PubMed ID: 8061411
    [TBL] [Abstract][Full Text] [Related]  

  • 48. DIFFERENTIATION OF EXOTOXIN AND OTHER BIOLOGICALLY ACTIVE SUBSTANCES IN PSEUDOMONAS PSEUDOMALLEI FILTRATES.
    HECKLY RJ
    J Bacteriol; 1964 Dec; 88(6):1730-6. PubMed ID: 14240963
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chronic sinusitis with nasal polyps: staphylococcal exotoxin immunoglobulin E and cellular inflammation.
    Conley DB; Tripathi A; Ditto AM; Reid K; Grammer LC; Kern RC
    Am J Rhinol; 2004; 18(5):273-8. PubMed ID: 15586797
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis of endogenous pyrogen by rabbit leukocytes.
    Moore DM; Murphy PA; Chesney PJ; Wood WB
    J Exp Med; 1973 May; 137(5):1263-74. PubMed ID: 4573840
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Free-solution isoelectric focusing for the purification of Staphylococcus aureus enterotoxin C1.
    St Clair NL; Sax M
    Protein Expr Purif; 1990 Nov; 1(2):97-103. PubMed ID: 2136241
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Large-scale purification of staphylococcal enterotoxins A, B, and C2 by dye ligand affinity chromatography.
    Brehm RD; Tranter HS; Hambleton P; Melling J
    Appl Environ Microbiol; 1990 Apr; 56(4):1067-72. PubMed ID: 2339869
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Toxicity of recombinant toxic shock syndrome toxin 1 and mutant toxins produced by Staphylococcus aureus in a rabbit infection model of toxic shock syndrome.
    Bonventre PF; Heeg H; Cullen C; Lian CJ
    Infect Immun; 1993 Mar; 61(3):793-9. PubMed ID: 8432600
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of toxicity of streptococcal pyrogenic exotoxin A mutants.
    Roggiani M; Stoehr JA; Leonard BA; Schlievert PM
    Infect Immun; 1997 Jul; 65(7):2868-75. PubMed ID: 9199461
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Host-parasite factors in group A streptococcal infections. Pyrogenic and other effects of immunologic distinct exotoxins related to scarlet fever toxins.
    WATSON DW
    J Exp Med; 1960 Feb; 111(2):255-84. PubMed ID: 13783427
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Possible relationship between streptococcal pyrogenic exotoxin A and Kawasaki syndrome in patients older than six months of age.
    Nomura Y; Masuda K; Yoshinaga M; Takei S; Miyata K
    Pediatr Infect Dis J; 2003 Sep; 22(9):794-8. PubMed ID: 14506370
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Group A streptococcal pyrogenic exotoxin: pyrogenicity, alteration of blood-brain barrier, and separation of sites for pyrogenicity and enhancement of lethal endotoxin shock.
    Schlievert PM; Watson DW
    Infect Immun; 1978 Sep; 21(3):753-63. PubMed ID: 361577
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Purification and properties of succinic oxidase factor, an extracellular product of Staphylococcus aureus.
    Gemmell CG
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Dec; 258(4):431-40. PubMed ID: 6099943
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Demonstration of interleukin 1 activity in apparently homogeneous specimens of the pI 5 form of rabbit endogenous pyrogen.
    Hanson DF; Murphy PA
    Infect Immun; 1984 Aug; 45(2):483-90. PubMed ID: 6611312
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pseudomonas aeruginosa exotoxin: purification by preparative polyacrylamide gel electrophoresis and the development of a highly specific antitoxin serum.
    Callahan LT
    Infect Immun; 1976 Jul; 14(1):55-61. PubMed ID: 820647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.